Article
Salt Lake City-Research from the Moran Eye Center, University of Utah School of Medicine, Salt Lake City, showed that low ocular levels of the antioxidants lutein and zeaxanthin could contribute to age-related macular degeneration (AMD).
Bausch + Lomb launches its enVista Aspire monofocal and toric IOLs in the European Union
California dreaming: 2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco
4DMT refocuses pipeline to prioritize 4D-150 trials in wet AMD and DME
Connect, learn, and innovate in a family-friendly atmosphere: What to expect at EnVision Summit 2025
Formycon partners with Teva, Klinge Biopharma for commercialization of aflibercept biosimilar FYB203 (AHZANTIVE)
Bausch + Lomb acquires Whitecap Biosciences